Committed to developing treatments for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
Laurent Pharmaceuticals to participate at the Biotech Showcase, January 8-10th 2018, San Francisco, CA, USA
Laurent Pharmaceuticals to participate at the BioPharm America, September 26-27th 2017, Boston, MA, USA
Laurent Pharmaceuticals reaches agreement with US Cystic Fibrosis Foundation to increase Development Award to $US 5M
Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis